Fingerprint
Dive into the research topics of 'Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?
Margaret A. Lindorfer, Adrian Wiestner, Clive S. Zent, Ronald P. Taylor
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations